Your doctor's post-cataract surgery treatment plan may include PROLENSA® because of its many features

Treatment of inflammation and pain after cataract surgery

  • PROLENSA® reduced inflammation in eyes as early as 8 days after cataract surgery
  • About 4 out of 5 patients taking PROLENSA® were pain-free the day after surgery with one dose given the day of surgery*

*Individual results may vary

Designed with patient comfort in mind

  • PROLENSA® has a pH similar to human tears
  • Patients treated with PROLENSA® reported less stinging, scratchiness, redness, and sensitivity to light compared to placebo

Consistent dosing

  • With PROLENSA®, you get the same amount of treatment with every drop, every time
  • PROLENSA® only needs to be used once a day
  • No shaking is required with PROLENSA®

Established treatment

  • PROLENSA® has been prescribed for over 5 years with more than 2.7 million prescriptions and counting
  • PROLENSA® is a product of Bausch + Lomb, a leading global eye-health company with over a 160-year history
What to Expect After Cataract Surgery

Indications and usage

PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery.

Important Safety Information

  • PROLENSA® contains sodium sulfite, a substance that may cause allergic reactions, some severe, in certain people. In addition, tell your doctor if you have had an allergic reaction to any other medications.
  • Slow or delayed healing may occur while using non-steroidal anti-inflammatory drugs (NSAIDs) such as PROLENSA®.
  • Use of NSAIDs in the eye may result in certain serious eye conditions that can be sight threatening. Tell your doctor immediately about any side effect that you may have.
  • Replace bottle cap after using and do not touch dropper tip to any surface in order to avoid contamination of the bottle.
  • Remove contact lenses prior to using PROLENSA®. The preservative in PROLENSA®, benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may be reinserted after 10 minutes following administration of PROLENSA®.
  • If more than one eye medicine is being used, use the eye medicines at least 5 minutes apart.
  • The most common side effects (seen in 3%-8% of patients) were inflammation of the eye, foreign body sensation, eye pain, light sensitivity, and blurred vision.

Please click here for full Prescribing Information for PROLENSA®.

You are encouraged to report side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

©Bausch & Lomb Incorporated. All rights reserved. PRA.0044.USA.18